Clin2
NCT06617182Possibly a fitRecruiting

Thalidomide and glutamine for radiation bowel injury

Radiation Enteritis

Treatments studied

Part of Digestive system clinical trials.

This trial tests whether combining thalidomide and glutamine helps people with bleeding caused by past radiation treatment to the abdomen or pelvis. The medication may reduce inflammation and help healing.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
150 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old
  • You have bleeding from the rectum or bloody stools after cancer radiation therapy
  • Bleeding happens at least 1 out of 5 times you have a bowel movement
  • You are able to care for yourself and are out of bed more than half the day (ECOG 0-2)
  • You do not have active cancer in the stomach or intestines

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07759258Not yet recruiting
GLP-2 hormone and bowel inflammation after abdominal radiation

This study looks at how a hormone called GLP-2 (which helps protect the gut) changes during radiation therapy to the belly or pelvis, and whether it relates to side effects like radiation enteritis (inflammation of the gut). The goal is to better understand and possibly predict these side effects to improve care.

NCT06410443Recruiting
Steroid treatment for radiation-induced bowel injury

This trial tests if local steroids can help heal bowel damage caused by radiation therapy for cancer. It may reduce pain, bleeding, and urgency, and improve quality of life.

Shenyang, Liaoning
NCT06772480Not yet recruiting
Thalidomide vs argon plasma coagulation for stomach bleeding in cirrhosis

This trial compares two treatments for anemia caused by GAVE, a condition with bleeding stomach blood vessels. It tests a medication (thalidomide) against a procedure (argon plasma coagulation) to see which is better at improving anemia in people with cirrhosis.

New Delhi, National Capital Territory of Delhi
NCT06530576Recruiting· Phase 2
Thalidomide for symptomatic large granular lymphocytic leukemia

This trial tests the drug thalidomide for people with symptomatic large granular lymphocytic leukemia (LGLL), a rare blood cancer. It aims to see if thalidomide can help control the disease and improve symptoms like low blood counts or an enlarged spleen.

Tianjin, Tianjin Municipality
NCT07837713Not yet recruiting· Phase 3
Chlorophyllin for bleeding from radiation-treated gut

This study tests a supplement called chlorophyllin to see if it can help stop bleeding in the gut caused by past radiation therapy. If you have had such bleeding, taking this supplement might reduce the bleeding and help you feel better.

Mumbai, Maharashtra
NCT06382519Recruiting
Thalidomide for Very Early-Onset IBD in Kids

This study tests whether the drug thalidomide can help children with very early-onset inflammatory bowel disease (VEOIBD) when their symptoms are moderate to severe. It aims to see if thalidomide can calm the inflammation and improve quality of life.

Shanghai, Shanghai Municipality

Hear when a new Radiation Enteritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.